Digital twins are increasingly being utilized across various industries (constructions, manufacturing, transportation, smart cities) and more recently in the healthcare sector by enabling more efficient, predictive, and data-driven decision-making.
The use of Digital twins in the pharma R&D sector leverages in silico models to expedite drug development and increase translational success for the benefit of the patient. Digital Twins can help to predict future behaviour’s and offer more precise and customized medicine specific to a patient, virtualize clinical trials to bring new medicines and vaccines to market faster.
Within this webinar we will explore how some Life Sciences companies are looking to use the digital twins to accelerate drug discovery and development in order to deliver safe products to patients.
Speakers
- Julia Schueler, Charles River Laboratories
- Damien Valour, Servier
- Bruce Church, Aitia
Register below